Disclosure Plus

EuBiologics Co., Ltd. Files Application for Phase 1 IND for Alzheimer’s Vaccine ‘PADIVAX’ in South Korea

Shin Ha-yeon
2026-08-18 14:23:36
[Edaily Reporter Shin Ha-yeon ] EuBiologics Co., Ltd.(206650)announced on the 18th that it has submitted an application to the South Korean Ministry of Food and Drug Safety (MFDS) for approval of a Phase 1 clinical trial plan (IND) for “PADIVAX,” a vaccine for Alzheimer’s disease.

This clinical trial will be conducted as a single-center, double-blind, randomized, placebo-controlled study to evaluate the safety, tolerability, and immunogenicity of PADIVAX in patients with mild cognitive impairment and mild Alzheimer’s disease caused by Alzheimer’s disease.

The target sample size is 24 participants, who will be enrolled in low-, medium-, and high-dose groups, respectively, and will receive a total of five doses of the investigational drug at four-week intervals. Safety will be evaluated for up to 52 weeks following the final dose. The clinical trial period is 60 months from the date of approval by the Institutional Review Board (IRB).

The company stated that it plans to immediately disclose relevant details upon approval of the clinical trial protocol.

Economy

Corporation

IT·Science

Economy

[37th SRE][Issue] BBB-Rated Market Stifled by the JR and JoongAng Crisis

“The bond market should be a universal channel for corporate financing, but right now it’s like an exclusive social club.”This was the point raised by an advisory committee member during a meeting hel…
2026-11-18 10:30:05

Corporation

'Gyochon Makgeolli' Served at APEC Banquet… Available at the Grand Hyatt Hotel

KYOCHON FOOD&BEVERAGE, operator of the Kyochon Chicken franchise, is expanding its sales channels for traditional Korean liquor by introducing its premium makgeolli, “Eunhwasu: A Night of Stargazing 1…
2026-11-18 09:50:52

IT·Science

K-Games Dominate Google Play's 'Game of the Year' List

Google Play announced the “2026 Best of the Year” on the 18th, highlighting the apps and games that were most popular among users over the past year. In South Korea, Nexon’s “Maple Grow” was…
2026-11-18 11:22:31